New AI Framework Aims to Personalize HER2-Positive Breast Cancer Treatment
A new artificial intelligence approach published in Nature targets more personalized treatment for HER2-positive breast cancer. The framework focuses on spatially interpretable AI, suggesting it analyzes the spatial patterns within tumor tissue to help guide therapeutic decisions.
HER2-positive breast cancer is characterized by overexpression of the HER2 protein, which drives